Orexin a levels of adolescents with major depressive disorder

References

• Akça ÖF, Uzun N, Kılınç İ. 2020. Orexin A in adolescents with anxiety disorders. Int J Psychiatry Clin Pract. 24(2):127–134.
   PubMed Web of Science ®Google Scholar
• Aksu K, Firat Güven S, Aksu F, Ciftci B, Ulukavak Ciftci T, Aksaray S, Sipit T, Peker Y. 2009. Obstructive sleep apnoea, cigarette smoking and plasma orexin-A in a sleep clinic cohort. J Int Med Res. 37(2):331–340.
   PubMed Web of Science ®Google Scholar
• Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. 1999. Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 38(10):1230–1236.
   PubMed Web of Science ®Google Scholar
• Brundin L, Björkqvist M, Petersén Å, Träskman-Bendz L. 2007. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol. 17(9):573–579.
   PubMed Web of Science ®Google Scholar
• Cengiz M, Karaj V, Kocabasoğlu N, Gozubatik-Celik G, Dirican A, Bayoglu B. 2019. Orexin/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder. Int J Psychiatry Clin Pract. 23(2):114–121.
   PubMed Web of Science ®Google Scholar
• Gokler B, Unal F, Pehlivanturk B, Cengel- Kultur E, Akdemir D, Taner Y. 2004. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T). Turkish J Child Adolesc Ment Heal. 11:109–116.
   Google Scholar
• Grafe LA, Bhatnagar S. 2018. Orexins and stress. Front Neuroendocrinol. 51:132–145.
   PubMed Web of Science ®Google Scholar
• Hunt NJ, Rodriguez ML, Waters KA, Machaalani R. 2015. Changes in orexin (hypocretin) neuronal expression with normal aging in the human hypothalamus. Neurobiol Aging. 36(1):292–300.
   PubMed Web of Science ®Google Scholar
• Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Träskman-Bendz L, Goddard AW, Brundin L, Shekhar A. 2010. A key role for orexin in panic anxiety. Nat Med. 16(1):111–115.
   PubMed Web of Science ®Google Scholar
• Karaceylan F. 2005. Reliability and validity of SCARED in Turkish children (In Turkish) dissertation [Expertise Thesis]. Kocaeli University, Turkey.
   Google Scholar
• Kastin AJ, Akerstrom V. 1999. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther. 289:219–223.
   PubMed Web of Science ®Google Scholar
• Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. 1997. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 36(7):980–988.
   PubMed Web of Science ®Google Scholar
• Khairuddin S, Aquili L, Heng BC, Hoo TLC, Wong KH, Lim LW. 2020. Dysregulation of the orexinergic system: a potential neuropeptide target in depression. Neurosci Biobehav Rev. 118:384–396.
   PubMed Web of Science ®Google Scholar
• Kovacs M. 1985. The children’s depression inventory. Psychopharmacol Bull. 21:995–998.
   PubMed Web of Science ®Google Scholar
• Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. 2007. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 64(6):651–660.
   PubMed Web of Science ®Google Scholar
• Nakabayashi M, Suzuki T, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Date F, Takeyama J, Darnel AD, Moriya T, et al. 2003. Orexin-A expression in human peripheral tissues. Mol Cell Endocrinol. 205(1-2):43–50.
   PubMed Web of Science ®Google Scholar
• Oy B. 1991. Validity and reliability of Turkish version of child depression inventory. Turkish J Psychiatry. 2:132–136.
   Google Scholar
• Ozsoy S, Olguner Eker O, Abdulrezzak U, Esel E. 2017. Relationship between orexin A and childhood maltreatment in female patients with depression and anxiety. Soc Neurosci. 12(3):330–336.
   PubMed Web of Science ®Google Scholar
• Rice F, Riglin L, Lomax T, Souter E, Potter R, Smith DJ, Thapar AK, Thapar A. 2019. Adolescent and adult differences in major depression symptom profiles. J Affect Disord. 243:175–181.
   PubMed Web of Science ®Google Scholar
• Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T. 2011. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. J Affect Disord. 131(1-3):186–192.
   PubMed Web of Science ®Google Scholar
• Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DG, Ghatei MA, Bloom SR. 2001. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol. 13(6):561–566.
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Brügel M, Kratzsch J, Strauss M, Sander C, Baum P, Thiery J, Hegerl U, Schönknecht P. 2010. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett. 483(1):20–22.
   PubMed Web of Science ®Google Scholar
• Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett R-M, Pan Z, Brietzke E, McIntyre RS. 2019. Evaluating the role of orexins in the pathophysiology and treatment of depression: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 92:1–7.
   PubMed Web of Science ®Google Scholar
• Strawn JR, Pyne-Geithman GJ, Ekhator NN, Horn PS, Uhde TW, Shutter LA, Baker DG, Geracioti TD. 2010. Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology. 35(7):1001–1007.
   PubMed Web of Science ®Google Scholar
• Ünal F, Öktem F, Çetin Çuhadaroğlu F, Çengel Kültür E, Akdemir D, Foto Özdemir D, Çak HT, Ünal D, Tiraş K, Aslan C, et al. 2019. Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turk J Psychiatry. 30:42–50.
   Google Scholar
• Von der Goltz C, Koopmann A, Dinter C, Richter A, Grosshans M, Fink T, Wiedemann K, Kiefer F. 2011. Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Horm. Behav. 60(5):644–650.
   PubMed Web of Science ®Google Scholar
• Wight RG, SepÚlveda JE, Aneshensel CS. 2004. Depressive symptoms: how do adolescents compare with adults? J Adolesc Health. 34(4):314–323.
   PubMed Web of Science ®Google Scholar
• Young E, Korszun A. 2010. Sex, trauma, stress hormones and depression. Mol. Psychiatry. 15(1):23–28.
   PubMed Web of Science ®Google Scholar